Boehringer Ingelheim and Ochre Bio partner on liver disease in deal worth over $1bn Chronic liver disease and associated cirrhosis account for one million deaths every year
New clinical study to advance development of treatments for liver cirrhosis The £30m ADVANCE study is the most extensive study into liver disease worldwide